ADVISORY/Texas Heart Institute and St. Luke's Episcopal Hospital Announce Press Conference for Jarvik 2000 Clinical Trials.News/Assignment Editors & Health/Medical Writers ADVISORY...for Wednesday (May 3) --(BUSINESS WIRE) The Texas Heart Institute and St. Luke's Episcopal Hospital  This hospital-related article is a stub. You can help Wikipedia by [expanding it].St. will hold a press conference Wednesday, May 3 at 1101 Bates Bates , Katherine Lee 1859-1929. American educator and writer best known for her poem "America the Beautiful," written in 1893 and revised in 1904 and 1911. St., Houston, Texas, to provide an update regarding the Jarvik 2000(R) clinical trials and to introduce the first patient in the study. Sign in begins at 9:30 a.m. CST CST abbr. 1. Central Standard Time 2. convulsive shock treatment CST Central Standard Time Noun 1. with the conference to begin at 10:00 a.m. CST. About the size of a "C" battery, the Jarvik 2000 is a valveless, electrically powered miniature axial flow pump An axial flow pump is a common type of water pump that essentially consists of a propeller in a tube. The propeller can be driven directly by a sealed motor in the tube or by a right-angle drive shaft that pierces the tube. that fits directly into the left ventricle left ventricle n. The chamber on the left side of the heart that receives the arterial blood from the left atrium and contracts to force it into the aorta. and pushes oxygenated blood Oxygenated blood Blood carrying oxygen through the body. Mentioned in: Patent Ductus Arteriosus throughout the body. The Texas Heart Institute at St. Luke's Episcopal Hospital is the only cardiovascular center in the U.S. conducting clinical trials of this heart-assist device, which has been approved by the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. for evaluation as a bridge to transplant.
WHO: The Texas Heart Institute and St. Luke's Episcopal Hospital
WHAT: Press conference
WHEN: 9:30 a.m. CST (sign in begins)
10:00 a.m. CST (conference begins)
Wednesday, May 3, 2000
WHERE: Please pick up media badge at the Bates entrance of St.
Luke's Episcopal Hospital, 1101 Bates Street. You will then
be escorted to the conference site.
WHY: To provide an update regarding the Jarvik 2000 clinical
trials and to introduce the first patient in the study
PHOTO OPPS: -- Denton A. Cooley, MD, founder, president, and
surgeon-in-chief, Texas Heart Institute, and chief
of Cardiovascular Surgery, St. Luke's Episcopal
Hospital
-- Robert Jarvik, MD, President, Jarvik Heart Inc.
-- O.H. Frazier, MD, chief of Cardiopulmonary
Transplantation and director of Surgical Research
at the Texas Heart Institute, and chief of
Transplant Service at St. Luke's Episcopal Hospital
-- The first patient in the clinical trials of the
Jarvik 2000
|
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion